SBCメディカルグループホールディングス > IR information

IR information

Our Business

Our Business

CUSTOMER LANDSCAPE

  • Drivers of price sensitivity
  • Adoption lifestyle
  • Importance in the customer package
  • Membership
  • Key criteria & Quality
Growth of Company’s Revenue No.1 in Japan Over 40%++ of total market share in Japan
  • 20% annual average growth
    for 10 consecutive years
  • Revenue of about $1billion yen in FY2022
  • Overseas business is heading for profitable
    in United States so reduced advertising costs
MEDICAL PLATFORM OFPT
Average growth rate of 10 years +20% Average growth rate of 10 years +20% Repeat ratio Over 90% Repeat ratio Over 90%
CAGR of TAM 2021 to 2030 +9.7% CAGR of TAM 2021 to 2030 +9.7% Number of clinics 140++ Number of clinics 140++
KEY DRIVERS For this market will be the increasing demand for minimally invasive and non-invasive cosmetic surgeries IPs : 100++ KEY DRIVERS For this market will be the increasing demand for minimally invasive and non-invasive cosmetic surgeries IPs : 100++